Understanding PROMACTA


PROMACTA® (eltrombopag) is a platelet booster, also known as a TPO-RA (thrombopoietin receptor agonist). This means that it boosts the number of platelets your child’s body makes.


PROMACTA is the only once-daily oral platelet booster that is available as a tablet and an oral suspension. It is also the only oral platelet booster approved to treat chronic immune thrombocytopenia (ITP) in children 1 year and older.

How PROMACTA treats chronic ITP

How PROMACTA treats chronic ITP

A hormone called thrombopoietin (TPO) naturally creates platelets in the body and, unlike some other drugs used to treat chronic ITP, PROMACTA acts the same as TPO—working alongside your body to create more platelets.


PROMACTA is the only once-daily oral platelet booster that comes in both a tablet and an oral suspension, so even if your child can’t swallow a pill, they can still receive a once-daily oral therapy. Some other chronic ITP treatments require doctor visits for an injection, while PROMACTA can be taken at home, school, or on the go!

What makes PROMACTA different?

PROMACTA is the #1 platelet booster, prescribed to more than 200,000 people worldwide*


For pediatric patients, it's the only once-daily oral TPO-RA treatment for chronic ITP and it has the following features:
  • Can be given as an oral tablet or suspension
  • Can be given at home, without the need to visit a doctor's office for an injection
  • Fits in with an active lifestyle; can be given wherever you and your child go

*Source: IQVIA claims data for October 2018 to December 2019. Includes people with chronic immune thrombocytopenia, severe aplastic anemia, and chronic hepatitis C virus.